Invention Grant
US08722883B2 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
有权
嘧啶磺酰胺衍生物作为趋化因子受体调节剂
- Patent Title: Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent Title (中): 嘧啶磺酰胺衍生物作为趋化因子受体调节剂
-
Application No.: US13833363Application Date: 2013-03-15
-
Publication No.: US08722883B2Publication Date: 2014-05-13
- Inventor: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Cherylin Francis Preston , Jeffrey Paul Stonehouse , Neal Michael Smith
- Applicant: AstraZeneca AB
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Morgan, Lewis & Bockius LLP
- Priority: GB0419235.7 20040828; GB0502544.0 20050208
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61K31/506 ; A61P11/06
Abstract:
A compound of formula (I), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
Public/Granted literature
- US20130203991A1 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators Public/Granted day:2013-08-08
Information query
